ENDLOS-TURBO PUT - AMGEN | Market Closed - Deutsche Boerse AG 20:34:44 14/06/2024 BST | ||
| 3.37 EUR | +0.30% |
|
| Current month | +20.79% | ||
| 1 month | +47.81% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 3.37 | +0.30% |
| 13/06/24 | 3.36 | +4.67% |
| 12/06/24 | 3.21 | +3.22% |
| 11/06/24 | 3.11 | +11.07% |
| 10/06/24 | 2.8 | +4.09% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 08:34 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ2WA1 |
| ISIN | DE000DJ2WA18 |
| Date issued | 04/10/2023 |
| Strike | 333.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.367 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.27 € |
|---|---|
| Lowest since issue | 0.99 € |
| Spread | 0.06 € |
| Spread % | 1.77% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat